Eudaimonia Partners, LLC Gilead Sciences, Inc. Transaction History

Eudaimonia Partners, LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 24, 2023	BUY	$73.94 - $80.67 $13,531 - $14,762	183 Added 6.38%	3,053 $228,000
Q2 2023 Jul 19, 2023	SELL	$76.01 - $86.7 $19,990 - $22,802	-263 Reduced 8.39%	2,870 $221,000
Q1 2023 Apr 25, 2023	SELL	$77.31 - $88.08 $64,089 - $73,018	-829 Reduced 20.92%	3,133 $259,000
Q4 2022 Jan 24, 2023	SELL	$62.32 - $89.47 $15,455 - $22,188	-248 Reduced 5.89%	3,962 $0
Q3 2022 Nov 03, 2022	SELL	$59.54 - $68.01 $18,636 - $21,287	-313 Reduced 6.92%	4,210 $260,000
Q2 2022 Aug 09, 2022	BUY	$57.72 - $65.01 $63,665 - $71,706	1,103 Added 32.25%	4,523 $280,000
Q1 2022 May 16, 2022	BUY	$57.92 - $72.58 $198,086 - $248,223	3,420 New	3,420 $203,000
Q2 2021 Aug 13, 2021	SELL	$63.47 - $69.35 $200,692 - $219,284	-3,162 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$60.0 - $68.46 $53,640 - $61,203	-894 Reduced 22.04%	3,162 $204,000
Q4 2020 Feb 18, 2021	SELL	$56.65 - $64.55 $258,324 - $294,348	-4,560 Reduced 52.92%	4,056 $236,000
Q3 2020 Nov 23, 2020	BUY	$62.1 - $78.08 $535,053 - $672,737	8,616 New	8,616 $544,000
Q3 2020 Nov 16, 2020	SELL	$62.1 - $78.08 $250,138 - $314,506	-4,028 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$72.34 - $84.0 $55,050 - $63,924	-761 Reduced 15.89%	4,028 $310,000
Q1 2020 May 05, 2020	BUY	$62.63 - $80.22 $110,917 - $142,069	1,771 Added 58.68%	4,789 $358,000
Q4 2019 May 05, 2020	BUY	$61.62 - $67.78 $185,969 - $204,560	3,018 New	3,018 $196,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Eudaimonia Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Eudaimonia Partners, LLC with notifications on news.